Earnings Outlook For Harmony Biosciences
Portfolio Pulse from Benzinga Insights
Harmony Biosciences (NASDAQ:HRMY) is set to release its quarterly earnings report on October 29, 2024. Analysts expect an EPS of $0.66. Investors are keen on not just an earnings beat but also positive future guidance. The company's past performance shows a tendency for share price changes post-earnings announcements.
October 28, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Harmony Biosciences is expected to report an EPS of $0.66. Investors are looking for an earnings beat and positive guidance, which could impact the stock price.
The upcoming earnings report is crucial as it could influence the stock price based on whether the company beats the EPS estimate and provides positive guidance. Past performance shows significant price changes post-earnings, indicating potential volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100